
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by
our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact
Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/articles/bayer-wins-roundup-cancer-case-ahead-of-supreme-court-decision-11654858130
Listen to article
(2 minutes)
Bayer notched a third consecutive court victory in the U.S. over its Roundup weedkiller after a jury in Missouri rejected a claim that it causes cancer days before an eagerly anticipated Supreme Court announcement on a key case.
The Supreme Court is expected to announce next week whether it would hear Bayer’s bid to dismiss a Roundup case. Should the court take up the case and ultimately find in favor of the German agricultural and pharmaceutical giant, Bayer says it would largely end thousands of claims that have dogged it since taking over Monsanto Co., the product’s original owner, in 2018.
Continue reading your article witha WSJ membership
WSJ Membership
Customer Service
Tools & Features
Ads
More
Dow Jones Products
WSJ Membership
Customer Service
Tools & Features
Ads
More
Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by
our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact
Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

